154 related articles for article (PubMed ID: 10795415)
1. A method for the rapid detection of the zopiclone degradation product 2-amino-5-chloropyridine.
Galloway JH; Marsh ID; Newton CM; Forrest AR
Sci Justice; 1999; 39(4):253-6. PubMed ID: 10795415
[TBL] [Abstract][Full Text] [Related]
2. Testing for zopiclone in hair application to drug-facilitated crimes.
Villain M; Chèze M; Tracqui A; Ludes B; Kintz P
Forensic Sci Int; 2004 Oct; 145(2-3):117-21. PubMed ID: 15451082
[TBL] [Abstract][Full Text] [Related]
3. Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone, in blood, urine, and hair.
Laloup M; Ramirez Fernandez Mdel M; De Boeck G; Wood M; Maes V; Samyn N
J Anal Toxicol; 2005 Oct; 29(7):616-26. PubMed ID: 16419390
[TBL] [Abstract][Full Text] [Related]
4. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS.
Kintz P; Villain M; Concheiro M; Cirimele V
Forensic Sci Int; 2005 Jun; 150(2-3):213-20. PubMed ID: 15944062
[TBL] [Abstract][Full Text] [Related]
5. Drug-facilitated sexual assault and analytical toxicology: the role of LC-MS/MS A case involving zolpidem.
Kintz P; Villain M; Dumestre-Toulet V; Ludes B
J Clin Forensic Med; 2005 Feb; 12(1):36-41. PubMed ID: 15763689
[TBL] [Abstract][Full Text] [Related]
6. Zopiclone misuse: an update from Dublin.
Bannan N; Rooney S; O'connor J
Drug Alcohol Rev; 2007 Jan; 26(1):83-5. PubMed ID: 17364840
[TBL] [Abstract][Full Text] [Related]
7. Identification and quantitation of zopiclone in biological matrices using gas chromatography-mass spectrometry (GC-MS).
Rohrig TP; Norton MC; Harryman LA
Methods Mol Biol; 2010; 603():527-33. PubMed ID: 20077105
[TBL] [Abstract][Full Text] [Related]
8. Screening, identification and determination of the two new hypnotics zolpidem and zopiclone.
Ahrens B; Schütz H; Seno H; Weiler G
Arzneimittelforschung; 1994 Jul; 44(7):799-802. PubMed ID: 7945511
[TBL] [Abstract][Full Text] [Related]
9. First derivative spectrofluorimetric determination of zopiclone and its degradation product, 2-amino-5-chloropyridine, in pharmaceutical formulations with preliminary tool in biological fluids for clinical evidence of zopiclone intake.
Al-Attas AS; Nasr JJ; Shalan S; Belal F
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jun; 181():148-152. PubMed ID: 28359903
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of zopiclone, N-desmethylzopiclone, zopiclone N-oxide and 2-amino-5-chloropyridine in urine using LC-MS-MS.
Nilsson GH; Kugelberg FC; Ahlner J; Kronstrand R
J Anal Toxicol; 2014; 38(6):327-34. PubMed ID: 24790062
[TBL] [Abstract][Full Text] [Related]
11. Detection of 2-amino-5-chloropyridine in urine as a parameter of zopiclone (Imovane) intake using HPLC with diode array detection.
Mannaert E; Tytgat J; Daenens P
J Anal Toxicol; 1997; 21(3):208-12. PubMed ID: 9171204
[TBL] [Abstract][Full Text] [Related]
12. Stability tests of zopiclone in whole blood.
Nilsson GH; Kugelberg FC; Kronstrand R; Ahlner J
Forensic Sci Int; 2010 Jul; 200(1-3):130-5. PubMed ID: 20434282
[TBL] [Abstract][Full Text] [Related]
13. Analysis of zopiclone (Imovane) in postmortem specimens by GC-MS and HPLC with diode-array detection.
Van Bocxlaer J; Meyer E; Clauwaert K; Lambert W; Piette M; De Leenheer A
J Anal Toxicol; 1996; 20(1):52-4. PubMed ID: 8837952
[TBL] [Abstract][Full Text] [Related]
14. [Detection of zopiclone in many drivers--a sign of misuse or abuse].
Bramness JG; Skurtveit S; Mørland J
Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2820-1. PubMed ID: 10494203
[TBL] [Abstract][Full Text] [Related]
15. A method for screening for various sedative-hypnotics in serum by liquid chromatography/single quadrupole mass spectrometry.
Miyaguchi H; Kuwayama K; Tsujikawa K; Kanamori T; Iwata YT; Inoue H; Kishi T
Forensic Sci Int; 2006 Feb; 157(1):57-70. PubMed ID: 15869852
[TBL] [Abstract][Full Text] [Related]
16. Methods for the analysis of nonbenzodiazepine hypnotic drugs in biological matrices.
Tonon MA; Bonato PS
Bioanalysis; 2012 Feb; 4(3):291-304. PubMed ID: 22303833
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of zopiclone and its degradation product and main impurity (2-amino-5-chloropyridine) by micellar liquid chromatography with time-programmed fluorescence detection: preliminary investigation for biological monitoring.
El-Shaheny RN; Alattas A; Nasr JJ; El-Enany N; Belal F
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():49-55. PubMed ID: 22999478
[TBL] [Abstract][Full Text] [Related]
18. Validation of an LC-MS/MS method for the determination of zopiclone, N-desmethylzopiclone and 2-amino-5-chloropyridine in whole blood and its application to estimate the original zopiclone concentration in stored specimens.
Nilsson GH; Kugelberg FC; Ahlner J; Kronstrand R
Int J Legal Med; 2015 Mar; 129(2):269-77. PubMed ID: 25069820
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of zopiclone and its impurity by four different spectrophotometric methods.
Abdelrahman MM; Naguib IA; El Ghobashy MR; Ali NA
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():617-24. PubMed ID: 25244295
[TBL] [Abstract][Full Text] [Related]
20. Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach.
Montenarh D; Hopf M; Maurer HH; Schmidt P; Ewald AH
Anal Bioanal Chem; 2014 Jan; 406(3):803-18. PubMed ID: 24309624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
